Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Citi raises Omega Healthcare stock target to $32, keeps neutral stance

EditorNatashya Angelica
Published 03/18/2024, 05:19 PM
Updated 03/18/2024, 05:19 PM
© Reuters.

On Monday, Citi updated its view on Omega Healthcare Investors (NYSE:OHI), increasing the stock's price target to $32.00 from the previous $30.00 while maintaining a Neutral rating. This adjustment follows the company's fourth-quarter earnings, which led to revisions in the operating and transaction assumptions within Citi's model for Omega Healthcare.

The revised model now reflects a decrease in the estimated normalized Funds From Operations (FFO) for the year 2024, moving from $2.82 to $2.75. However, the expectations for the year 2025 remain stable with the normalized FFO still projected at $2.95. The analyst from Citi believes that the revised price target is warranted due to the increasingly positive sentiment towards the skilled nursing sector.

Omega Healthcare Investors is a real estate investment trust (REIT) that focuses on the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. The company's performance is closely watched by investors interested in the healthcare real estate sector.

The adjustment in the price target reflects the latest financial data and industry conditions that analysts consider when evaluating the potential value of a stock. It's an indicator of how external factors such as market sentiment and company performance can influence analyst expectations and investment outlooks.

Investors and market observers often look to such updates from financial institutions to gauge the market's view on specific stocks. These price targets and ratings are tools used by investors to make informed decisions about buying, holding, or selling securities.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.